Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma

Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review, compilation of risk assessment criteria. J Med Genet 41(2):81–91

Singh AD, Damato B, Howard P, Harbour JW (2005) Uveal melanoma: genetic aspects. Ophthalmol Clin North Am 18(1): 85–97, viii

Singh AD, Rennie IG, Seregard S, Giblin M, McKenzie J (2004) Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol 49(4):419–428

Barker-Griffith AE, Streeten BW (2004) Familial uveal melanoma: a report of four cases in two families and literature review. Can J Ophthalmol 39(4):403–408

Kodjikian L, Nguyen K, Lumbroso L et al (2003) Familial uveal melanoma: a report on two families and a review of the literature. Acta Ophthalmol Scand 81(4):389–395

Hearle N, Damato BE, Humphreys J et al (2003) Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci 44(2):458–462

Scott RJ, Vajdic CM, Armstrong BK et al (2002) BRCA2 mutations in a population-based series of patients with ocular melanoma. Int J Cancer 102(2):188–191

Iscovich J, Abdulrazik M, Cour C, Fischbein A, Pe’er J, Goldgar DE (2002) Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Int J Cancer 98(1):42–44

Sinilnikova OM, Egan KM, Quinn JL et al (1999) Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer 82(3):325–328

Jonsson G, Bendahl PO, Sandberg T et al (2005) Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst 97(18):1377–1382

Singh AD, Shields CL, De Potter P et al (1996) Familial uveal melanoma. Clinical observations on 56 patients. Arch Ophthalmol 114(4):392–399

Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792

Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71

Lynch HT, Smyrk TC, Watson P et al (1993) Genetics, natural history, tumor spectrum, pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549

Canning CR, Hungerford J (1988) Familial uveal melanoma. Br J Ophthalmol 72(4):241–243

Hemminki K, Jiang Y (2001) Association of ocular melanoma with breast cancer but not with cutaneous melanoma: results from the Swedish Family-Cancer Database. Int J Cancer 94(6):907–909

Diener-West M, Reynolds SM, Agugliaro DJ et al (2005) Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25. Arch Ophthalmol 123(5):601–604

Bergman L, Nilsson B, Ragnarsson-Olding B, Seregard S (2006) Uveal melanoma: a study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci 47(1):72–77

Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89(3):227–238

Couch FJ, DeShano ML, Blackwood MA et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336(20):1409–1415

Shattuck-Eidens D, Oliphant A, McClure M et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278(15):1242–1250

Chen S, Wang W, Lee S et al (2006) Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 296(12):1479–1487

Wijnen JT, Vasen HF, Khan PM et al (1998) Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339(8):511–518

Breslow NE, Day NE (1987) Statistical methods in cancer research. In: Breslow NE, Day NE (eds) The design and analysis of cohort studies. International Agency for Research on Cancer, Lyon

Taeger D, Sun Y, Keil U, Straif K (2000) A stand-alone windows applications for computing exact person-years, standardized mortality ratios, confidence intervals in epidemiological studies. Epidemiology 11(5):607–608

Soufir N, Bressac-de Paillerets B, Desjardins L et al (2000) Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Br J Cancer 82(4):818–822

Lynch HT, Brand RE, Hogg D et al (2002) Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 94(1):84–96

Hemminki K, Chen B (2006) Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database. Melanoma Res 16(2):191–195

Davidorf FH, Abdel-Rahman MH, Craven M-A, Ohr M, Jarjoura D (2007) Higher colon cancer risk in uveal melanoma patients and their relatives compared to general population. Invest Ophthalmol Vis Sci 48(5):4790